Moreover, astrocytes are considered to be an important player in AD pathogenesis, with emerging data suggesting that plasma GFAP levels may be a promising biomarker for early AD diagnosis.84, 85, 86, 87. The gene discussed is GFAP; the disease is Alzheimer disease.